Loading...

Francesco Caiazza, PhD

Title(s)Employee of Contracting Firm, Pharmaceutical Chemistry
SchoolSchool of Pharmacy
Address600 16th St
San Francisco CA 94158
Phone415-476-8147
ORCID ORCID Icon0000-0003-4228-1130 Additional info
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Collaboration Interests
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence]. G Ital Cardiol (Rome). 2020 Sep; 21(9):687-738. Gulizia Chairperson MM, Parrini Co-Chairperson I, Colivicchi Co-Chairperson F, Bisceglia I, Caiazza F, Gensini GF, Mureddu GF, Santomauro M, Ageno W, Ambrosetti M, Aspromonte N, Barni S, Bellocci F, Caldarola P, Carletti M, De Luca L, Di Fusco SA, Di Lenarda A, Di Nisio M, Domenicucci S, Enea I, Francese GM, Lestuzzi C, Lucà F, Maurea N, Nassiacos D, Pedretti RFE, Pusineri E, Roscio G, Rossini R, Russo A, Volterrani M, Gabrielli Co-Chairperson D. PMID: 33094745.
      View in: PubMed   Mentions:    Fields:    
    2. The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts. Biol Chem. 2019 11 26; 400(12):1629-1638. Ivry SL, Knudsen GM, Caiazza F, Sharib JM, Jaradeh K, Ravalin M, O'Donoghue AJ, Kirkwood KS, Craik CS. PMID: 31256057.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment. Am J Pathol. 2019 10; 189(10):1916-1932. Caiazza F, Oficjalska K, Tosetto M, Phelan JJ, Noonan S, Martin P, Killick K, Breen L, O'Neill F, Nolan B, Furney S, Power R, Fennelly D, Craik CS, O'Sullivan J, Sheahan K, Doherty GA, Ryan EJ. PMID: 31404541.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Depleted polymorphonuclear leukocytes in human metastatic liver reflect an altered immune microenvironment associated with recurrent metastasis. Cancer Immunol Immunother. 2018 07; 67(7):1041-1052. Hand F, Harmon C, Elliott LA, Caiazza F, Lavelle A, Maguire D, Hoti E, Nolan N, Geoghegan JG, Ryan EJ, O'Farrelly C. PMID: 29572702.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    5. Immunoproteasome functions explained by divergence in cleavage specificity and regulation. Elife. 2017 11 28; 6. Winter MB, La Greca F, Arastu-Kapur S, Caiazza F, Cimermancic P, Buchholz TJ, Anderl JL, Ravalin M, Bohn MF, Sali A, O'Donoghue AJ, Craik CS. PMID: 29182146.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    6. Hepatic microenvironment: What tips the balance towards metastasis. Hepato Pancreato Biliary. 2016 Apr 1; 18:e60-e61. F. Hand, C. Harmon, L. Elliott, F. Caiazza, N. Nolan, J. Geoghegan, E. Ryan, C. O'Farrelly. .
      View in: Publisher Site   Mentions:
    7. Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells. Endocr Relat Cancer. 2016 Apr; 23(4):323-34. PMID: 26932782.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    8. Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells. Br J Cancer. 2015 Jun 09; 112(12):1895-903. PMID: 26010411.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    9. Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential. Clin Exp Immunol. 2015 Jul; 181(1):39-50. PMID: 25943872.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    10. Estrogen receptors and their implications in colorectal carcinogenesis. Front Oncol. 2015; 5:19. PMID: 25699240.
      View in: PubMed   Mentions:
    11. Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies. Biomark Med. 2015; 9(4):363-75. PMID: 25808440.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    12. Oocyte maturation: a story of arrest and release. Front Biosci (Schol Ed). 2013 Jan 01; 5:451-77. PMID: 23277062.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    13. ADAM-17: a novel therapeutic target for triple negative breast cancer. Ann Oncol. 2013 Feb; 24(2):362-369. PMID: 22967992.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    14. Cytosolic phospholipase A2-a expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours. Br J Cancer. 2011 Jan 18; 104(2):338-44. PMID: 21119660.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    15. Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth. Mol Endocrinol. 2010 May; 24(5):953-68. Caiazza F, Harvey BJ, Thomas W. PMID: 20211985.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    16. Estrogen, phospholipase A and breast cancer. Front Biosci. 2008 Jan 01; 13:2604-13. Thomas W, Caiazza F, Harvey BJ. PMID: 17981737.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    17. 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun. 2007 Jul 20; 359(1):102-7. Caiazza F, Galluzzo P, Lorenzetti S, Marino M. PMID: 17524358.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    18. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer. 2007 Mar; 14(1):153-67. Galluzzo P, Caiazza F, Moreno S, Marino M. PMID: 17395984.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    Francesco's Networks
    Concepts (111)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑